Company Filing History:
Years Active: 2018
Title: MiYoung Kwon: Innovator in Binocular Vision Research
Introduction
MiYoung Kwon is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of vision science, particularly in understanding binocular vision impairment. Her innovative work has led to the development of a patented system that quantifies inter-ocular suppression.
Latest Patents
MiYoung Kwon holds a patent for her invention titled "Quantification of inter-ocular suppression in binocular vision impairment." This patent describes systems, apparatus, and methods designed to quantify inter-ocular suppression. The technology involves a stimulus presentation device and a controller that presents different stimuli to each eye of a patient. The stimuli can include letters, numbers, or shapes arranged in rows and columns. The combined contrast of corresponding stimuli is set to a predetermined value, which can be adjusted based on the patient's feedback and an algorithm executed by the controller. This innovative approach allows for the determination and quantification of suppression in terms of visual field location.
Career Highlights
Throughout her career, MiYoung Kwon has focused on advancing the understanding of visual impairments. Her work has been instrumental in developing methods that enhance the assessment of binocular vision issues. With her patent, she has opened new avenues for research and clinical applications in vision science.
Collaborations
MiYoung has collaborated with notable colleagues in her field, including Peter Bex and Steven Dakin. These collaborations have further enriched her research and contributed to the advancement of knowledge in binocular vision.
Conclusion
MiYoung Kwon is a trailblazer in the field of binocular vision research, with her patented technology paving the way for improved understanding and treatment of vision impairments. Her contributions are invaluable to both the scientific community and those affected by visual disorders.